123 related articles for article (PubMed ID: 16912182)
1. Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouse.
Dai B; Kim O; Xie Y; Guo Z; Xu K; Wang B; Kong X; Melamed J; Chen H; Bieberich CJ; Borowsky AD; Kung HJ; Wei G; Ostrowski MC; Brodie A; Qiu Y
Cancer Res; 2006 Aug; 66(16):8058-64. PubMed ID: 16912182
[TBL] [Abstract][Full Text] [Related]
2. Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells.
Dai B; Chen H; Guo S; Yang X; Linn DE; Sun F; Li W; Guo Z; Xu K; Kim O; Kong X; Melamed J; Qiu S; Chen H; Qiu Y
Cancer Res; 2010 Jul; 70(13):5587-96. PubMed ID: 20570899
[TBL] [Abstract][Full Text] [Related]
3. Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor.
Guo W; Liu R; Bhardwaj G; Yang JC; Changou C; Ma AH; Mazloom A; Chintapalli S; Xiao K; Xiao W; Kumaresan P; Sanchez E; Yeh CT; Evans CP; Patterson R; Lam KS; Kung HJ
Cell Death Dis; 2014 Sep; 5(9):e1409. PubMed ID: 25188519
[TBL] [Abstract][Full Text] [Related]
4. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells.
Qiu Y; Robinson D; Pretlow TG; Kung HJ
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3644-9. PubMed ID: 9520419
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
6. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin.
Xue LY; Qiu Y; He J; Kung HJ; Oleinick NL
Oncogene; 1999 Jun; 18(22):3391-8. PubMed ID: 10362360
[TBL] [Abstract][Full Text] [Related]
7. Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells.
Bagheri-Yarmand R; Mandal M; Taludker AH; Wang RA; Vadlamudi RK; Kung HJ; Kumar R
J Biol Chem; 2001 Aug; 276(31):29403-9. PubMed ID: 11382770
[TBL] [Abstract][Full Text] [Related]
8. Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells.
Kim O; Jiang T; Xie Y; Guo Z; Chen H; Qiu Y
Oncogene; 2004 Mar; 23(10):1838-44. PubMed ID: 14981536
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase ETK/BMX is up-regulated in bladder cancer and predicts poor prognosis in patients with cystectomy.
Guo S; Sun F; Guo Z; Li W; Alfano A; Chen H; Magyar CE; Huang J; Chai TC; Qiu S; Qiu Y
PLoS One; 2011 Mar; 6(3):e17778. PubMed ID: 21408190
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase Etk/BMX protects nasopharyngeal carcinoma cells from apoptosis induced by radiation.
Zhang Z; Zhu W; Zhang J; Guo L
Cancer Biol Ther; 2011 Apr; 11(7):690-8. PubMed ID: 21339702
[TBL] [Abstract][Full Text] [Related]
11. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
[TBL] [Abstract][Full Text] [Related]
12. Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferation.
Chau CH; Chen KY; Deng HT; Kim KJ; Hosoya K; Terasaki T; Shih HM; Ann DK
Oncogene; 2002 Dec; 21(57):8817-29. PubMed ID: 12483534
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Etk/Bmx protects against ischemic brain injury.
Chen KY; Wu CC; Chang CF; Chen YH; Chiu WT; Lou YH; Chen YH; Shih HM; Chiang YH
Cell Transplant; 2012; 21(1):345-54. PubMed ID: 21929872
[TBL] [Abstract][Full Text] [Related]
14. Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage.
Jiang T; Guo Z; Dai B; Kang M; Ann DK; Kung HJ; Qiu Y
J Biol Chem; 2004 Nov; 279(48):50181-9. PubMed ID: 15355990
[TBL] [Abstract][Full Text] [Related]
15. CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors.
Guo W; Liu R; Bhardwaj G; Ma AH; Changou C; Yang JC; Li Y; Feng C; Luo Y; Mazloom A; Sanchez E; Wang Y; Huang W; Patterson R; Evans CP; Lam KS; Kung HJ
PLoS One; 2013; 8(8):e70910. PubMed ID: 23967135
[TBL] [Abstract][Full Text] [Related]
16. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
Guo L; Zhou Y; Sun Y; Zhang F
Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
[TBL] [Abstract][Full Text] [Related]
17. Ligand-independent activation of the arylhydrocarbon receptor by ETK (Bmx) tyrosine kinase helps MCF10AT1 breast cancer cells to survive in an apoptosis-inducing environment.
Fujisawa Y; Li W; Wu D; Wong P; Vogel C; Dong B; Kung HJ; Matsumura F
Biol Chem; 2011 Oct; 392(10):897-908. PubMed ID: 21861773
[TBL] [Abstract][Full Text] [Related]
18. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells.
Guo L; Chen P; Zhou Y; Sun Y
Exp Mol Pathol; 2010 Jun; 88(3):401-6. PubMed ID: 20206622
[TBL] [Abstract][Full Text] [Related]
19. The expression and role of tyrosine kinase ETK/BMX in renal cell carcinoma.
Zhuang J; Tu X; Cao K; Guo S; Mao X; Pan J; Huang B; Chen X; Gao Y; Qiu S
J Exp Clin Cancer Res; 2014 Mar; 33(1):25. PubMed ID: 24606948
[TBL] [Abstract][Full Text] [Related]
20. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
